- CA$2.13bn
- CA$2.05bn
- $656.00m
- 67
- 37
- 74
- 61
2019 February 28th | 2020 February 29th | 2021 February 28th | 2022 February 28th | 2023 February 28th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 904 | 1,040 | 893 | 718 | 656 |
Cost of Revenue | |||||
Gross Profit | 700 | 768 | 643 | 467 | 419 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 844 | 1,189 | 2,000 | 720 | 1,381 |
Operating Profit | 60 | -149 | -1,107 | -2 | -725 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 77 | -148 | -1,113 | 19 | -720 |
Provision for Income Taxes | |||||
Net Income After Taxes | 93 | -152 | -1,104 | 12 | -734 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 93 | -152 | -1,104 | 12 | -734 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 0 | -152 | -1,104 | 12 | -734 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.019 | -0.22 | -1.29 | -0.031 | -0.543 |